Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The announcements reflect a broader wave of major ...

Roche and Genentech Announce New North Carolina Manufacturing Facility Share Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its ...

Roche’s Genentech unit has announced a $700 million investment in a new 700,000-square-foot drug manufacturing facility in Holly Springs, NC. According to the company, the site will support its ...

Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The planned Holly Springs facility, spanning 700,000 ...

SOUTH SAN FRANCISCO, Calif., May 12, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million in a new 700,000 square foot ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the United States ...

The new facility, based in Holly Springs, North Carolina, will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines. Separately, Roche also announced plans ...

Roche and Genentech Announce New North Carolina Manufacturing Facility Provided by Business Wire May 12, 2025, 12:30:00 PM Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma ...

(Reuters) -Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to expand its presence in the ...